DFCM
CHRS icon

Dark Forest Capital Management’s Coherus Oncology CHRS Stock Holding History

Dark Forest Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,002
Closed -$8.88K – 1221
2025
Q1 		$8.88K Buy
11,002
+645
+6% +$742 ﹤0.01% 1196
2024
Q4 		$14.3K Buy
+10,357
New +$11.6K ﹤0.01% 887
2023
Q2 		– Sell
-9,686
Closed -$66.3K – 1085
2023
Q1 		$66.3K Buy
+9,686
New +$75.2K 0.02% 777
2022
Q4 		– Sell
-1,129
Closed -$11K – 1196
2022
Q3 		$11K Buy
+1,129
New +$11.4K ﹤0.01% 720
2022
Q1 		– Sell
-159
Closed -$3K – 1331
2021
Q4 		$3K Buy
+159
New +$2.78K ﹤0.01% 1252

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Dark Forest Capital Management's CHRS Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Coherus Oncology (CHRS) in Q2 2025, closing a stake of 11,002 shares — an estimated $8.88K sold.

Dark Forest Capital Management first reported a position in CHRS in Q4 2021 and held it in 5 quarters. The position peaked at $66.3K in Q1 2023. 112 funds tracked by Wall St. Rank hold CHRS as of Q2 2025.

  • Dark Forest Capital Management reported no remaining Coherus Oncology position as of Q2 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 11,002 Coherus Oncology shares in Q2 2025, an estimated $8.88K.
  • Dark Forest Capital Management first reported a position in Coherus Oncology in Q4 2021 and held it in 5 quarters.
  • Dark Forest Capital Management's Coherus Oncology position peaked at $66.3K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.